Abstract

WE have previously reported an increase in and β-globulins and an increase in β-lipoprotein after administration of the anabolic steroid, 17-ethyl-19-nortestosterone (norethandrolone) (Fig. 1A) to human subjects1, and our subsequent work (unpublished) disclosed that this increase in serum protein fractions is associated with increases in protein bound carbohydrates (Fig. 2). We have recently had the opportunity to study the effects of an anabolic steroid with a unique chemical configuration, oxandrolone (Fig. 1B), in eleven patients with disorders of lipid metabolism. This compound was found to cause a marked increase in α2-globulin (P 0.001) in all the patients studied (Fig. 3). The increases in α2-globulin and glycoprotein were definitive in all the eleven patients 5 weeks after the start of oxandrolone therapy. Thus it seems that both these anabolic steroids significantly enhance the concentrations of plasma glycoprotein.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.